DERIPHYLLIN INJECTION 2 ML

Content Reviewed By:

Written By:

• DERIPHYLLIN INJECTION 2 ML is a bronchodilator and is primarily used to alleviate breathing difficulties associated with various respiratory conditions. It effectively widens the airways, making it easier for air to flow in and out of the lungs. This is particularly beneficial for individuals suffering from asthma, chronic bronchitis, and emphysema, where airway constriction is a major problem.
• This injection provides rapid relief during acute asthma attacks or exacerbations of chronic obstructive pulmonary disease (COPD). Its fast-acting nature ensures that patients experiencing severe breathlessness receive timely intervention, preventing further complications and potential hospitalization. The medication works by relaxing the muscles surrounding the airways, opening them up for improved airflow.
• DERIPHYLLIN INJECTION 2 ML helps reduce wheezing, shortness of breath, and chest tightness, which are common symptoms of respiratory distress. By improving airflow, it enables patients to breathe more comfortably and engage in daily activities with greater ease. This can significantly enhance their quality of life and overall well-being.
• The medication contains both theophylline and etofylline, which work synergistically to provide enhanced bronchodilation. Theophylline relaxes the smooth muscles in the airways, while etofylline helps to reduce inflammation and further open the airways. This dual action makes DERIPHYLLIN INJECTION 2 ML a potent and effective treatment for respiratory conditions.
• DERIPHYLLIN INJECTION 2 ML can be used as part of a comprehensive treatment plan for managing chronic respiratory conditions. It is often administered alongside other medications, such as inhaled corticosteroids and beta-agonists, to provide optimal control of symptoms and prevent future exacerbations. Regular use, as prescribed by a healthcare professional, can help patients maintain stable respiratory function and minimize the impact of their condition on their daily lives.
• In cases of severe bronchospasm that are unresponsive to other treatments, DERIPHYLLIN INJECTION 2 ML can be a life-saving intervention. Its ability to quickly dilate the airways and improve oxygenation can prevent respiratory failure and other serious complications. Healthcare providers often rely on this medication to manage critical respiratory emergencies and stabilize patients in distress.
• DERIPHYLLIN INJECTION 2 ML improves the ability to cough up mucus, helping to clear the airways of accumulated secretions. This is especially beneficial for patients with chronic bronchitis or other conditions that cause excessive mucus production. By facilitating mucus clearance, the injection reduces the risk of infection and further airway obstruction.

• DERIPHYLLIN INJECTION 2 ML is administered intravenously or intramuscularly by a healthcare professional. The dosage and frequency are determined by the patient's condition, weight, and response to the medication. The intravenous route is preferred for acute conditions requiring rapid bronchodilation.
• For intravenous administration, DERIPHYLLIN INJECTION 2 ML is typically diluted in a compatible intravenous solution, such as normal saline or dextrose solution. The diluted solution is then infused slowly over a period of 20-30 minutes to minimize the risk of adverse effects such as hypotension or arrhythmias. The rate of infusion is carefully monitored by the healthcare provider.
• Intramuscular injections are administered deep into a large muscle mass, such as the gluteus maximus. The injection site should be rotated with each subsequent dose to prevent local irritation or tissue damage. Patients should be advised to report any pain, redness, or swelling at the injection site.
• Dosage adjustments may be necessary based on the patient's age, renal function, liver function, and concurrent medications. Elderly patients and those with impaired renal or liver function may require lower doses to avoid toxicity. Serum theophylline levels should be monitored periodically to ensure that the medication is within the therapeutic range. Regular monitoring helps in preventing both subtherapeutic levels and toxic concentrations.
• Before administering DERIPHYLLIN INJECTION 2 ML, it is essential to assess the patient's medical history, including any history of heart disease, hypertension, seizures, or thyroid disorders. Patients with these conditions may be at increased risk of adverse effects. The medication should be used with caution in pregnant or breastfeeding women.
• Patients should be educated about the potential side effects of DERIPHYLLIN INJECTION 2 ML, such as nausea, vomiting, headache, insomnia, and palpitations. They should be instructed to report any concerning symptoms to their healthcare provider promptly. It’s also important to inform them about potential interactions with other medications they may be taking, including over-the-counter drugs and herbal supplements.